SVB Leerink Maintains Outperform on Macrogenics, Raises Price Target to $40
SVB Leerink analyst Jonathan Chang maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target from $37 to $40.
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
